Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Citi expects Intel to beat Q2 guidance By Investing.com
© Reuters. Citi expects Intel (INTC) to beat Q2 guidance Citi analysts reiterated a Neutral rating and a $29.50 per share price target on Intel
WD-40 gains on Q3 beat, PriceSmart falls By Investing.com
© Reuters After-hours movers: WD-40 gains on Q3 beat, PriceSmart falls VOXX International Corporation (NASDAQ:) 16% LOWER; EPS of ($0.45), $0.41 worse than the analyst
Kura Sushi shares jump after earnings beat By Investing.com
© Reuters. Investing.com — Kura Sushi USA Inc (NASDAQ:) shares were jumping as the conveyor belt Japanese restaurant chain beat expectations for earnings. Shares were
Wells Fargo pops on Q1 EPS, NII beat By Investing.com
© Reuters. Wells Fargo (WFC) pops on Q1 EPS, NII beat By Senad Karaahmetovic Wells Fargo (NYSE:) shares are trading higher in pre-open Friday after
Givaudan’s quarterly sales beat expectations By Reuters
© Reuters. FILE PHOTO: The logo of Swiss flavours and fragrances maker Givaudan is seen at its innovation center in Kemptthal, Switzerland January 10, 2020.
AI Can Write a Song, but It Can't Beat the Market
Quants have tried for decades with limited success at the biggest challenge. Source link
Will Nucor (NUE) Beat Estimates Again in Its Next Earnings Report?
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly
Why Con Ed (ED) is Poised to Beat Earnings Estimates Again
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly
Why Hercules Tech (HTGC) Could Beat Earnings Estimates Again
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the
Will Regeneron (REGN) Beat Estimates Again in Its Next Earnings Report?
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Regeneron
